Receptor-interacting protein-1 promotes the growth and invasion in gastric cancer

Zhu,Guangwei; Ye,Jianxin; Huang,Yongjian; Zheng,Wei; Hua,Jin; Yang,Shugang; Zhuang,Jinfu; Wang,Jinzhou

doi:10.3892/ijo.2016.3455

Receptor-interacting protein-1 promotes the growth and invasion in gastric cancer

Authors:
- Guangwei Zhu
- Jianxin Ye
- Yongjian Huang
- Wei Zheng
- Jin Hua
- Shugang Yang
- Jinfu Zhuang
- Jinzhou Wang
View Affiliations

Affiliations: Department of Gastrointestinal Surgery Section II, The First Hospital Affiliated to Fujian Medical University, Fuzhou, Fujian, P.R. China
Published online on: March 24, 2016 https://doi.org/10.3892/ijo.2016.3455
Pages: 2387-2398

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The receptor-interacting protein-1 (RIP-1) is an important molecular in inflammation signaling pathways, but the role of RIP-1 in gastric cancer is largely unknown. In this study, we tested the expression of RIP-1 in gastric cancer samples and analyzed the effects of expression of RIP-1 on the prognosis in gastric cancer patients. We analyzed the role of the RIP-1 in gastric cancer cells and addressed the functional role of RIP-1 using a xenograft mouse model. A lentivirus-based effective RIP-1 siRNA vector was infected into HGC and AGS cells. The effect of RIP-1 siRNA on HGC and AGS cells were investigated by cell proliferation assay and invasion assay. Furthermore, we examined the role of RIP-1-siRNA on HGC cells in the mice with subcutaneous xenograft tumor, and preliminarily analyzed the underlying mechanisms. The results indicated that the expression of RIP-1 in the gastric cancer tissues was significantly higher than the expression in the normal gastric tissues. Additionally, RIP-1 immunoreactivity was positive at the site of invasion, but little or no immunoreactivity was detected at the gastric cancer parts of interstitial substance. Gastric cancer patients with high expression of RIP-1 had a poor survival rate. RIP-1 expression in the gastric cancer cell lines were general. HGC-R-1-RNAi-LV inhibited HGC and AGS cell proliferation and invasion ability in vitro. RIP-NF-κB/AP-1-VEGF-C signaling pathways have a crucial role in the regulate the biological functions of HGC cells. HGC-R-1-RNAi-LV suppressed tumor growth in the HGC cell subcutaneous xenograft model. In conclusion, our data indicate that RIP-1 promote the growth and invasion of gastric cancer in vitro and in vivo, additionally providing evidence that targeting RIP-1 may be useful in the treatment of gastric cancer.

View Figures

View References

1	Ferlay JSI, Ervik M, et al: GLOBOCAN 2012v1.0, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 11 (Internet). International Agency for Research on Cancer; Lyon: 2013, http://globocan.iarc.fr. Accessed Apr 25, 2014
2	Carneiro F: Stomach cancer. World Cancer Report 2014. Steward B and Wild CP: International Agency for Research on Cancer; Lyon: pp. 383–391. 2014
3	Waters JP, Pober JS and Bradley JR: Tumour necrosis factor in infectious disease. J Pathol. 230:132–147. 2013. View Article : Google Scholar : PubMed/NCBI
4	O'Donnell MA and Ting AT: RIP1 comes back to life as a cell death regulator in TNFR1 signaling. FEBS J. 278:877–887. 2011. View Article : Google Scholar : PubMed/NCBI
5	Stanger BZ, Leder P, Lee TH, Kim E and Seed B: RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 81:513–523. 1995. View Article : Google Scholar : PubMed/NCBI
6	Hur GM, Lewis J, Yang Q, Lin Y, Nakano H, Nedospasov S and Liu ZG: The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes Dev. 17:873–882. 2003. View Article : Google Scholar : PubMed/NCBI
7	Devin A, Lin Y and Liu ZG: The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep. 4:623–627. 2003. View Article : Google Scholar : PubMed/NCBI
8	Bradley JR and Pober JS: Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene. 20:6482–6491. 2001. View Article : Google Scholar : PubMed/NCBI
9	Ting AT, Pimentel-Muiños FX and Seed B: RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J. 15:6189–6196. 1996.PubMed/NCBI
10	Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA, et al: The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res. 69:2809–2816. 2009. View Article : Google Scholar : PubMed/NCBI
11	Han W, Xie J, Fang Y, Wang Z and Pan H: Nec-1 enhances shikonin-induced apoptosis in leukemia cells by inhibition of RIP-1 and ERK1/2. Int J Mol Sci. 13:7212–7225. 2012. View Article : Google Scholar : PubMed/NCBI
12	Liu XY, Lai F, Yan XG, Jiang CC, Guo ST, Wang CY, Croft A, Tseng HY, Wilmott JS, Scolyer RA, et al: RIP1 kinase is an oncogenic driver in melanoma. Cancer Res. 75:1736–1748. 2015. View Article : Google Scholar : PubMed/NCBI
13	Azijli K, Yuvaraj S, Peppelenbosch MP, Würdinger T, Dekker H, Joore J, van Dijk E, Quax WJ, Peters GJ, de Jong S, et al: Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells. J Cell Sci. 125:4651–4661. 2012. View Article : Google Scholar : PubMed/NCBI
14	Zhu G, Du Q, Wang X, Tang N, She F and Chen Y: TNF-α promotes gallbladder cancer cell growth and invasion through autocrine mechanisms. Int J Mol Med. 33:1431–1440. 2014.PubMed/NCBI
15	Nikolaou VA, Stratigos AJ, Flaherty KT and Tsao H: Melanoma: New insights and new therapies. J Invest Dermatol. 132:854–863. 2012. View Article : Google Scholar : PubMed/NCBI
16	Liu ZG, Hsu H, Goeddel DV and Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell. 87:565–576. 1996. View Article : Google Scholar : PubMed/NCBI
17	Karin M, Cao Y, Greten FR and Li ZW: NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer. 2:301–310. 2002. View Article : Google Scholar : PubMed/NCBI
18	Pacifico F and Leonardi A: NF-kappaB in solid tumors. Biochem Pharmacol. 72:1142–1152. 2006. View Article : Google Scholar : PubMed/NCBI
19	Wang CY, Cusack JC Jr, Liu R and Baldwin AS Jr: Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med. 5:412–417. 1999. View Article : Google Scholar : PubMed/NCBI
20	Festjens N, Vanden Berghe T, Cornelis S and Vandenabeele P: RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ. 14:400–410. 2007. View Article : Google Scholar : PubMed/NCBI
21	Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ and Barker PA: cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell. 30:689–700. 2008. View Article : Google Scholar : PubMed/NCBI
22	Imre G, Larisch S and Rajalingam K: Ripoptosome: A novel IAP-regulated cell death-signalling platform. J Mol Cell Biol. 3:324–326. 2011. View Article : Google Scholar : PubMed/NCBI
23	Niu J, Shi Y, Iwai K and Wu ZH: LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. EMBO J. 30:3741–3753. 2011. View Article : Google Scholar : PubMed/NCBI
24	Blackwell K, Zhang L, Workman LM, Ting AT, Iwai K and Habelhah H: Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed IκB kinase activation. Mol Cell Biol. 33:1901–1915. 2013. View Article : Google Scholar : PubMed/NCBI
25	Zhu G, Chen X, Wang X, Li X, Du Q, Hong H, Tang N, She F and Chen Y: Expression of the RIP-1 gene and its role in growth and invasion of human gallbladder carcinoma. Cell Physiol Biochem. 34:1152–1165. 2014. View Article : Google Scholar : PubMed/NCBI
26	Lee TH, Shank J, Cusson N and Kelliher MA: The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J Biol Chem. 279:33185–33191. 2004. View Article : Google Scholar : PubMed/NCBI
27	Jüttner S, Wissmann C, Jöns T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W and Höcker M: Vascular endothelial growth factor-D and its receptor VEGFR-3: Two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol. 24:228–240. 2006. View Article : Google Scholar
28	Choi JH, Oh YH, Park YW, Baik HK, Lee YY and Kim IS: Correlation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma. J Korean Med Sci. 23:592–597. 2008. View Article : Google Scholar : PubMed/NCBI
29	Chen Y, Jiang L, She F, Tang N, Wang X, Li X, Han S and Zhu J: Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism. Mol Cell Biochem. 345:77–89. 2010. View Article : Google Scholar : PubMed/NCBI
30	Bantounas I, Phylactou LA and Uney JB: RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J Mol Endocrinol. 33:545–557. 2004. View Article : Google Scholar : PubMed/NCBI
31	Kawasaki H and Taira K: Short hairpin type of dsRNAs that are controlled by tRNA (Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 31:700–707. 2003. View Article : Google Scholar : PubMed/NCBI
32	Caplen NJ and Mousses S: Short interfering RNA (siRNA)-mediated RNA interference (RNAi) in human cells. Ann NY Acad Sci. 1002:56–62. 2003. View Article : Google Scholar
33	Yang B, Tuo S, Tuo CW, Zhang N and Liu QZ: Establishment of a nude mouse model of highly metastatic gastric lymphoma constructed with orthotopic transplantation of surgical specimen. Zhonghua Wei Chang Wai Ke Za Zhi. 13:436–439. 2010.PubMed/NCBI